Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CheckMate901: Nivolumab Combinations vs Chemotherapy in Untreated Advanced Urothelial Cancer
NCT03036098Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2017
- Primary completion
- Aug 2024
- Countries
- 30
01
Overview
A Phase 3 trial of nivolumab in urothelial carcinoma (UC), sponsored by Bristol Myers Squibb. Started Mar 2017; status: completed.
02
Drugs
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03036098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03036098.